Checkpoint blockade – understanding mechanisms, unlocking new approaches

Birmingham, UK

19 March 2020

Immune checkpoint blockade has been making headlines for years, transforming therapy for several previously untreatable cancers. However, understanding of the science underlying this approach is emphatically incomplete. 

The BSI Tumour Immunology Group presents a one-day meeting focussing on the fascinating and diverse immune axes of the checkpoint blockade concept.

Keywords:
Immunology, cancer, immunotherapy, checkpoint, PD1, PDL1, immunosuppression, tumour microenvironment, tumour immunology, research, cancer research, T cell, inhibitory checkpoint, exhaustion, lymphocyte, cancer treatment, immune evasion.
 

« Back to all meetings